General American Investors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.24M Sell
20,000
-10,000
-33% -$3.42M 0.43% 55
2026
Q1
$10.6M Hold
30,000
0.69% 41
2025
Q4
$9.82M Hold
30,000
0.55% 50
2025
Q3
$8.47M Hold
30,000
0.49% 54
2025
Q2
$8.38M Sell
30,000
-5,000
-14% -$1.42M 0.54% 53
2025
Q1
$10.9M Hold
35,000
0.79% 39
2024
Q4
$9.12M Buy
35,000
+5,000
+17% +$1.48M 0.63% 47
2024
Q3
$9.67M Buy
30,000
+5,000
+20% +$1.64M 0.67% 47
2024
Q2
$7.81M Hold
25,000
0.54% 49
2024
Q1
$7.11M Buy
+25,000
New +$7.32M 0.51% 53

Other funds holding AMGN

General American Investors's AMGN Position: Q2 2026 in Review

General American Investors reduced its Amgen (AMGN) stake by 33% in Q2 2026, selling an estimated $3.42M and leaving 20,000 shares worth $7.24M. The position accounts for 0.43% of the portfolio, ranked #55.

General American Investors first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $10.9M in Q1 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • General American Investors held 20,000 shares of Amgen worth $7.24M as of Q2 2026.
  • General American Investors sold 10,000 Amgen shares in Q2 2026, an estimated $3.42M.
  • Amgen made up 0.43% of General American Investors's portfolio in Q2 2026, its #55 holding.
  • General American Investors first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • General American Investors's Amgen position peaked at $10.9M in Q1 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on General American Investors's 13F filing for Q2 2026, filed 31 Jul 2026.